Skip to main content
Figure 2 | Cardiovascular Diabetology

Figure 2

From: Changes in liraglutide-induced body composition are related to modifications in plasma cardiac natriuretic peptides levels in obese type 2 diabetic patients

Figure 2

Correlations between changes in ANP and body compositions following 12-week liraglutide treatment. Δ: The change of values following liraglutide treatment. ANP: A-type natriuretic peptides. SAT: subcutaneous adipose tissue. VAT: visceral adipose tissue. (A): Change in plasma ANP levels and change in body weight. (B): Change in plasma ANP levels and change in fat mass. (C): Change in plasma ANP levels and change in relative fat mass. (D): Change in plasma ANP levels and change in lean mass. (E): Change in plasma ANP levels and change in VAT areas. (F): Change in plasma ANP levels and change in SAT areas.

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840